Neurodevelopmental outcomes of children with congenital heart disease: A review

被引:53
|
作者
Howell, Heather B. [1 ]
Zaccario, Michele [1 ,2 ]
Kazmi, Sadaf H. [1 ]
Desai, Purnahamsi [1 ]
Sklamberg, Felice E. [1 ]
Mally, Pradeep [1 ]
机构
[1] NYU, Sch Med, Dept Pediat, 317 East 34th St,Suite 902, New York, NY 10016 USA
[2] Pace Univ, Dept Psychol, 41 Pk Row, New York, NY 10038 USA
关键词
HYPOTHERMIC CARDIOPULMONARY BYPASS; CEREBRAL-BLOOD-FLOW; QUALITY-OF-LIFE; ARTERIAL SWITCH OPERATION; APOLIPOPROTEIN-E GENOTYPE; NEONATAL CARDIAC-SURGERY; EMPIRICALLY BASED TOOL; SCHOOL-AGED CHILDREN; WHITE-MATTER INJURY; PH-STAT STRATEGIES;
D O I
10.1016/j.cppeds.2019.100685
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Congenital heart defects are the most common birth anomaly affecting approximately 1% of births. With improved survival in this population, there is enhanced ability to assess long-term morbidities including neurodevelopment. There is a wide range of congenital heart defects, from those with minimal physiologic consequence that do not require medical or surgical intervention, to complex structural anomalies requiring highly specialized medical management and intricate surgical repair or palliation. The impact of congenital heart disease on neurodevelopment is multifactorial. Susceptibility for adverse neurodevelopment increases with advancing severity of the defect with initial risk factors originating during gestation. Complex structural heart anomalies may pre-dispose the fetus to abnormal circulatory patterns in utero that ultimately impact delivery of oxygen rich blood to the fetal brain. Thus, the brain of a neonate born with complex congenital heart disease may be particularly vulnerable from the outset. That vulnerability is compounded during the newborn period and through childhood, as this population endures a myriad of medical and surgical interventions. For each individual patient, these factors are likely cumulative and synergistic with progression from fetal life through childhood. This review discusses the spectrum of risk factors that may impact neurodevelopment in children with congenital heart disease, describes current recommendations and practices for neurodevelopmental follow-up of children with congenital heart disease and reviews important neurodevelopmental trends in this high risk population.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Neurodevelopmental Outcomes in Congenital Heart Disease: A Review
    Milillo, Jennifer
    Bakar, Adnan
    CURRENT PEDIATRICS REPORTS, 2020, 8 (04) : 170 - 175
  • [2] Neurodevelopmental Outcomes in Congenital Heart Disease: A Review
    Jennifer Milillo
    Adnan Bakar
    Current Pediatrics Reports, 2020, 8 : 170 - 175
  • [3] Preschool Neurodevelopmental Outcomes in Children with Congenital Heart Disease
    Brosig, Cheryl L.
    Bear, Laurel
    Allen, Sydney
    Hoffmann, Raymond G.
    Pan, Amy
    Frommelt, Michele
    Mussatto, Kathleen A.
    JOURNAL OF PEDIATRICS, 2017, 183 : 80 - +
  • [4] Neurodevelopmental Outcomes in Children with Complex Congenital Heart Disease
    Bragg, Jennifer
    CURRENT PEDIATRICS REPORTS, 2019, 7 (02) : 21 - 26
  • [6] Neurodevelopmental Outcomes in Children with Complex Congenital Heart Disease
    Jennifer Bragg
    Current Pediatrics Reports, 2019, 7 : 21 - 26
  • [7] Neurodevelopmental Outcomes in Congenital Heart Disease
    Rollins, Caitlin K.
    Newburger, Jane W.
    CIRCULATION, 2014, 130 (14) : E124 - E126
  • [8] Supporting Optimal Neurodevelopmental Outcomes in Infants and Children With Congenital Heart Disease
    Peterson, Jennifer K.
    CRITICAL CARE NURSE, 2018, 38 (03) : 68 - 74
  • [9] Neurodevelopmental outcomes in children with congenital heart disease: the role of perioperative neuroimaging
    Hoskote, Aparna
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (10): : 974 - 975
  • [10] Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease
    Brosig, Cheryl L.
    Bear, Laurel
    Allen, Sydney
    Simpson, Pippa
    Zhang, Liyun
    Frommelt, Michele
    Mussatto, Kathleen A.
    CONGENITAL HEART DISEASE, 2018, 13 (05) : 700 - 705